DAPHNE CHIU: Open Payments
NPI 1104562495 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,179 in 156 payments from 29 companies in 2025. Trend: 2023 $3,984 · 2024 $3,570 · 2025 $3,179
Food & beverage: $3,179
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 26 | $350 |
| ABBVIE INC. | 8 | $270 |
| Teva Pharmaceuticals USA, Inc. | 16 | $251 |
| UCB, Inc. | 9 | $235 |
| Axsome Therapeutics, Inc. | 6 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $168 |
| GE HEALTHCARE | 7 | $164 |
| MDD US Operations, LLC | 15 | $158 |
| Lilly USA, LLC | 9 | $148 |
| Neurocrine BioSciences, Inc. | 6 | $147 |
Products named: NURTEC ODT, AUSTEDO XR, Symbravo, UBRELVY, HYQVIA, INGREZZA, Leqembi, KISUNLA.
Industry payments across FL — which companies pay providers there.
